The Oncology Journal Club Episode 21: COVID-19 and Vaccine Update

Pinterest LinkedIn Tumblr +

Welcome to Episode of 21 The Oncology Journal Club focused entirely on COVID-19 with Special Guest Professor Raina MacIntyre.

In today’s special COVID-19 Update episode, Eva Segelov chats once again to Professor Raina MacIntyre. Raina heads the Biosecurity Program at the Kirby Institute, which conducts research in epidemiology, vaccinology, bioterrorism prevention, public health and clinical trials in infectious diseases.

She is one of the world’s leading authorities on pandemics so we’re very lucky to have her take on COVID-19 globally, the vaccines and how these will impact cancer patients, the importance of ventilation and much more.

She also offers very practical advice, including simple actions such as testing air quality and improving ventilation in treatment rooms.

“Clinicians should test the ventilation in their rooms and if its bad, and if you haven’t got a window you can open, buy one of those air filters with a HEPA filter” Professor Raina MacIntyre

This episode will be of broad interest so we urge you to share this episode with family and friends so we can spread these important messages as widely as possible.


This Week’s Team:

Professor Eva Segelov

Eva Segelov

Professor Eva Segelov is a Medical Oncologist and is Director of Oncology at Monash University and Monash Health, Melbourne, Victoria, previously Senior Medical Oncologist at St Vincent’s Hospital, St Vincent’s Private Hospital and St Vincent’s Clinic and Associate Professor of Medicine, University of New South Wales.

Eva has an interest in academic clinical trials in GI and breast cancer and has been a member of the AGITG since 2003. She has clinical trials expertise, links with national and international trials groups, and extensive experience with adult medical education.

 

Special Guest: Professor Raina MacIntyre

Professor Raina McIntyre

Professor Raina MacIntyre is NHMRC Principal Research Fellow and Professor of Global Biosecurity. She heads the Biosecurity Program at the Kirby Institute, which conducts research in epidemiology, vaccinology, bioterrorism prevention, mathematical modelling, genetic epidemiology, public health and clinical trials in infectious diseases.

Her research falls under 4 areas: Personal protective equipment, Vaccinology, Epidemic response and emerging infectious diseases, and Bioterrorism prevention. She is a dual-specialist physician with training in epidemiology and modelling. Her research is underpinned by her medical training, vaccine program experience and extensive field outbreak investigation experience.

She is best known for research in the detailed understanding of the transmission dynamics and prevention of infectious diseases, particularly respiratory pathogens such as influenza, tuberculosis, bioterrorism agents and vaccine-preventable infections. She has led the largest body of research internationally on face masks and respirators in health care workers. Her research has been influential in informing guidelines for health workers on PPE.

She is involved in several research studies on COVID-19. She leads Biosecurity in Global Security PLuS and is interested in emerging threats to health security. She also designed and co-convenes a course, Bioterrorism and Health Intelligence, taken by students at UNSW and ASU.

Rachael Babin

Rachael Babin

Rachael Babin is Editor-in-Chief of The Oncology Newsletter and Publisher of www.oncologynews.com.au. For regular oncology updates for healthcare professionals, please subscribe to The Oncology Newsletter.

With thanks to Eva Segelov, Raina MacIntyre and Graham Knowles.

Share.

About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

Leave A Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.